Cargando…
Upregulation of Piezo1 Is a Novel Prognostic Indicator in Glioma Patients
PURPOSE: Previous study reported that Piezo1 was highly expressed in glioma and promoted the proliferation of glioma cells, suggesting that Piezo1 overexpression might contribute to the poor prognosis of patients. Thus, this study aimed to identify whether Piezo1 may become a new prognostic biomarke...
Autores principales: | Qu, Shanqiang, Li, Shuting, Hu, Zhicheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244349/ https://www.ncbi.nlm.nih.gov/pubmed/32547190 http://dx.doi.org/10.2147/CMAR.S251776 |
Ejemplares similares
-
Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients
por: Hu, Zhicheng, et al.
Publicado: (2020) -
EVA1C Is a Potential Prognostic Biomarker and Correlated With Immune Infiltration Levels in WHO Grade II/III Glioma
por: Hu, Zhicheng, et al.
Publicado: (2021) -
Transcription factor CASZ1 increases an oncogenic transcriptional process in tumorigenesis and progression of glioma cells
por: Mao, Chaofu, et al.
Publicado: (2022) -
Prognostic significance of cancer stemness‐associated genes in patients with gliomas
por: Qu, Shanqiang, et al.
Publicado: (2020) -
Identification of PIEZO1 as a potential prognostic marker in gliomas
por: Zhou, Wenjianlong, et al.
Publicado: (2020)